PHARMA-TRADE A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About PHARMA-TRADE A/S
PHARMA-TRADE A/S (CVR number: 87339815) is a company from GRIBSKOV. The company recorded a gross profit of 0 kDKK in 2023. The operating profit was -42.2 kDKK, while net earnings were 34.4 mDKK. The profitability of the company measured by Return on Assets (ROA) was 14.3 %, which can be considered good and Return on Equity (ROE) was 14 %, which can be considered good. The equity ratio, a key indicator for solidity, stood at 100 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. PHARMA-TRADE A/S's liquidity measured by quick ratio was 3770.3 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 2 884.42 | 62.24 | |||
Gross profit | 1 322.71 | 3.55 | |||
EBIT | - 489.35 | -66.85 | -57.92 | -17.97 | -42.22 |
Net earnings | 30 174.95 | 41 078.25 | 46 440.52 | 28 014.62 | 34 353.72 |
Shareholders equity total | 214 965.60 | 233 216.16 | 242 438.26 | 238 089.22 | 251 384.58 |
Balance sheet total (assets) | 225 085.99 | 234 374.10 | 246 922.70 | 238 104.22 | 251 404.58 |
Net debt | 6 862.36 | -1 209.34 | 645.61 | -3 108.61 | -4 943.91 |
Profitability | |||||
EBIT-% | -17.0 % | -107.4 % | |||
ROA | 13.6 % | 17.9 % | 19.3 % | 11.6 % | 14.3 % |
ROE | 14.3 % | 18.3 % | 19.5 % | 11.7 % | 14.0 % |
ROI | 13.6 % | 17.9 % | 19.3 % | 11.6 % | 14.3 % |
Economic value added (EVA) | 6 527.27 | 7 365.85 | 7 613.15 | 8 181.82 | 1 869.57 |
Solvency | |||||
Equity ratio | 95.5 % | 99.5 % | 98.2 % | 100.0 % | 100.0 % |
Gearing | 4.7 % | 0.5 % | 1.8 % | ||
Relative net indebtedness % | 242.1 % | -1880.7 % | |||
Liquidity | |||||
Quick ratio | 1.1 | 12.8 | 4.0 | 4 907.8 | 3 770.3 |
Current ratio | 1.1 | 12.8 | 4.0 | 4 907.8 | 3 770.3 |
Cash and cash equivalents | 3 136.13 | 2 328.49 | 3 808.83 | 3 108.61 | 4 943.91 |
Capital use efficiency | |||||
Trade debtors turnover (days) | 6.5 | ||||
Net working capital % | 50.8 % | 22019.7 % | |||
Credit risk | |||||
Credit rating | AA | AA | AA | A | A |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.